LDH (LACTATE DEHYDROGENASE) - CSF

LDH (LACTATE DEHYDROGENASE) - CSF is a specialized diagnostic biochemistry test designed to measure the activity of lactate dehydrogenase in cerebrospinal fluid (CSF). LDH is an intracellular enzyme found in various tissues, including the brain. Measuring CSF LDH levels is essential for differentiating between viral and bacterial meningitis, evaluating central nervous system (CNS) infections, detecting CNS leukemia or lymphoma involvement, and assessing tissue damage from stroke or hemorrhage.

Measurement of CSF LDH provides direct clinical insight into cellular damage and metabolic changes within the central nervous system. Because early identification of bacterial meningitis or CNS malignancy supports timely emergency and specialist intervention, specialized biochemical testing supplies essential clinical data for neurology, infectious disease, emergency medicine, and internal medicine evaluations.

The test requires a cerebrospinal fluid specimen obtained by a qualified physician via lumbar puncture under sterile clinical conditions, followed by precise analysis using automated laboratory spectrophotometric techniques. Results must always be interpreted in conjunction with the patient's clinical presentation, CSF cell counts, protein, glucose, and microbiological culture findings.

Benefits of LDH (LACTATE DEHYDROGENASE) - CSF Testing

• Provides a precise quantitative measurement of CSF lactate dehydrogenase enzyme activity.
• Helps differentiate between bacterial and viral meningitis.
• Assists neurologists and infectious disease specialists in evaluating central nervous system infections.
• Aids in detecting CNS involvement in leukemia, lymphoma, or metastatic tumors.
• Supports tracking of specialized neurological and critical care treatment plans.
• Complements CSF protein, glucose, cell count, and Gram stain panels.
• Utilizes precise laboratory spectrophotometric techniques for reliable quantitative results.
• Assists specialists in determining appropriate anti-infective or oncological management strategies.
• Provides dependable turnaround times to support specialized clinical care.
• Utilizes sterile lumbar puncture specimen collection procedures under medical supervision.

Clinical Indications and Applications

Neurological Screening: The primary clinical indication is evaluating patients presenting with symptoms of meningitis (such as severe headache, stiff neck, fever, altered mental status) or suspected central nervous system malignancies.

Clinical Assessment: The test is utilized when investigating CNS tissue injury following stroke, hemorrhage, or hypoxic-ischemic events.

Why Doctors Recommend This Test

Neurologists, infectious disease specialists, emergency physicians, and internal medicine specialists recommend this test when investigating acute central nervous system infections or neurological disorders. It delivers essential quantitative data required to guide safe clinical intervention.

Following proper lumbar puncture guidelines will ensure a smooth and efficient testing procedure.

What Happens During The Procedure?

The collection procedure involves obtaining a cerebrospinal fluid sample performed by a qualified physician via a lumbar puncture (spinal tap) using sterile technique under appropriate local anesthesia and supervision protocols.

Once obtained, the sample is sent immediately to the laboratory and tested using advanced spectrophotometric analyzers to quantify CSF LDH activity. The procedure requires careful sterile medical management.

Normal Reporting Time

The report for the LDH (LACTATE DEHYDROGENASE) - CSF test is generally available within 24 to 48 hours due to standard laboratory processing times. Results must be reviewed promptly with the referring neurologist or specialist.

Who Should Consider This Test?

• Patients evaluated for suspected bacterial or viral meningitis and central nervous system infections.
• Individuals investigated for CNS malignancy, stroke, or neurological trauma as directed by a clinician.

Understanding Test Results

Test results provide quantitative measurements of CSF LDH enzyme activity, evaluated against established laboratory reference ranges.

Normal Findings: Normal or low CSF LDH levels indicate the absence of significant central nervous system tissue destruction or active bacterial infection.

Abnormal Findings: Significantly elevated CSF LDH levels strongly suggest bacterial meningitis, tissue necrosis, or central nervous system malignancy, requiring immediate medical evaluation and treatment.

Clinical Limitations

Traumatic lumbar punctures (blood-stained CSF) can falsely elevate LDH levels due to red blood cell contamination; results must be correlated with CSF cell counts and visual appearance.

ImportantSafety Information

Severe headaches, high fevers, neurological deficits, or altered mental status require immediate emergency medical attention. Patients must consult their healthcare provider or specialist to interpret cerebrospinal fluid findings.